Diabetes Drug May Lower Risk of Autoimmune Diseases
A new study from South Korea has found that a common type of diabetes medicine may offer an unexpected benefit: a lower risk of autoimmune diseases.
The research focused on a class of drugs called SGLT-2 inhibitors, which are used to treat type 2 diabetes. These medications not only help control blood sugar but may also reduce the chances of developing serious conditions like rheumatoid arthritis and lupus.
Autoimmune diseases happen when the body’s immune system, which is supposed to fight off germs, mistakenly attacks its own healthy tissues. This can lead to swelling, pain, and damage in places like the joints, skin, muscles, and even major organs.
- Rheumatoid arthritis
- Lupus
- Scleroderma
Author's summary: Diabetes drug may lower autoimmune disease risk.